Skip to content
The Policy VaultThe Policy Vault

Gleevec (imatinib tablets) — Medica

Kaposi sarcoma

Initial criteria

  • age ≥ 18 years
  • Patient has tried at least one medication
  • Patient has relapsed or refractory disease

Approval duration

1 year